Phytochemical profile and therapeutic potential of Viscum album L.

Viscum album L., the European mistletoe, is a common species from the Viscaceae family. This evergreen hemiparasitic shrub grows on various trees and contains diverse, biologically active substances. Its chemical composition may vary depending on the time of harvest, species of the host tree and the manufacturing process. Among well-described and most active phytochemicals identified in V. album are lectins and viscotoxins, which play substantial role in cancer treatment because of their apoptotic and cytotoxic effects. Another group of compounds found in mistletoe are phenolic acids, phenylpropanoids and flavonoids with antioxidant and anti-inflammatory activities, which decrease blood pressure. Other mistletoe components include, among others, triterpenes with cytotoxic and apoptotic properties, and phytosterols, oligo- and polysaccharides. Extracts from the plant, especially aqueous, are applied in traditional and official medicine, among others in treating hypertension or arthritis. Potentially, it can also be used as a hepatoprotective or a sedative drug.

[1]  Edited,et al.  Herbal drugs and phytopharmaceuticals , 2016 .

[2]  E. Supriyanto,et al.  Preclinical and Clinical Effects of Mistletoe against Breast Cancer , 2014, BioMed research international.

[3]  O. Effiong Reduction in Serum Bilirubin Concentration Following Administration of Crude Leaf Extract of Viscum album (Mistletoe) in High Salt Fed Rats , 2014 .

[4]  M. Milićević,et al.  Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. , 2013, European journal of cancer.

[5]  J. Simard,et al.  Viscum album agglutinin-I (VAA-I) increases cell surface expression of cytoskeletal proteins in apoptotic human neutrophils , 2013, Human & experimental toxicology.

[6]  G. Francis,et al.  Novel GHB-derived natural products from European mistletoe (Viscum album) , 2013, Pharmaceutical biology.

[7]  G. Kienle,et al.  Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts--a case report. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  Hwa-Young Lee,et al.  Stereochemical assignment of five new lignan glycosides from Viscum album by NMR study combined with CD spectroscopy , 2012, Magnetic resonance in chemistry : MRC.

[9]  C. Schempp,et al.  A Novel Triterpene Extract from Mistletoe Induces Rapid Apoptosis in Murine B16.F10 Melanoma Cells , 2012, Phytotherapy research : PTR.

[10]  G. Francis,et al.  Novel aminoalkaloids from European mistletoe (Viscum album L.) , 2012 .

[11]  Mahfoozur Rahman,et al.  Sedative, antiepileptic and antipsychotic effects of Viscum album L. (Loranthaceae) in mice and rats. , 2012, Journal of ethnopharmacology.

[12]  O. Adaramoye,et al.  Methanolic extract of African mistletoe (Viscum album) improves carbohydrate metabolism and hyperlipidemia in streptozotocin-induced diabetic rats. , 2012, Asian Pacific journal of tropical medicine.

[13]  P. Perjési,et al.  Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence based medicine , 2012 .

[14]  G. Henze,et al.  A new development of triterpene acid‐containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia , 2012, Cell proliferation.

[15]  C. Socaciu,et al.  Antioxidant Activity of European Mistletoe (Viscum album) , 2012 .

[16]  Dvc Awang Mosby's Handbook of Herbs and Natural Supplements , 2011 .

[17]  S. Kaveri,et al.  Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2 , 2011, PloS one.

[18]  H. Kiene,et al.  Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters , 2011, BMC complementary and alternative medicine.

[19]  A. Pintea,et al.  HPLC Fingerprint of Bioactive Compounds and Antioxidant Activities of Viscum album from Different Host Trees , 2011 .

[20]  A. Moghadamnia,et al.  Antihyperglycemic and antioxidant activity of Viscum album extract , 2011 .

[21]  M. Choudhary,et al.  Characterization and Antiglycation Activity of Phenolic Constituents from Viscum album (European Mistletoe) , 2010 .

[22]  A. Sleem,et al.  Effect of Viscum album on acute hepatic damage caused by carbon tetrachloride in rats , 2010, Turkish Journal of Medical Sciences.

[23]  H. Kiene,et al.  Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies , 2010, Integrative cancer therapies.

[24]  J. Bao,et al.  Plant lectins: potential antineoplastic drugs from bench to clinic. , 2010, Cancer letters.

[25]  S. Kaveri,et al.  Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity. , 2009, Anticancer research.

[26]  R. Saller,et al.  Efficacy and Safety of Mistletoe Preparations (Viscum album) for Patients with Cancer Diseases , 2009, Complementary Medicine Research.

[27]  H. Kiene,et al.  Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research , 2009, Journal of experimental & clinical cancer research : CR.

[28]  N. E. Gardin Immunological response to mistletoe (Viscum album L.) in cancer patients: a four‐case series , 2009, Phytotherapy research : PTR.

[29]  S. Branković,et al.  Effects of Mistletoe (Viscum Album L., Loranthaceae) Extracts on Arterial Blood Pressure in Rats Treated with Atropine Sulfate and Hexocycline , 2009, Clinical and experimental hypertension.

[30]  M. Popović,et al.  Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo , 2008, Phytotherapy research : PTR.

[31]  K. Linde,et al.  Mistletoe therapy in oncology. , 2008, The Cochrane database of systematic reviews.

[32]  U. Pfüller,et al.  Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. , 2007, Planta medica.

[33]  A. Eno,et al.  Effect of crude aqueous leaf extract of Viscum album (mistletoe) in hypertensive rats , 2007 .

[34]  N. Arda,et al.  Antioxidant activity of Viscum album ssp. album. , 2006, Fitoterapia.

[35]  S. Kaveri,et al.  Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. , 2006, Cancer letters.

[36]  E. Kuepeli,et al.  Anti-Inflammatory and Antinociceptive Activity of Flavonoids Isolated from Viscum album ssp. album , 2006, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[37]  J. van Hattum,et al.  Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. , 2011, Arzneimittel-Forschung.

[38]  U. Pfüller,et al.  Complete structure determination of the A chain of mistletoe lectin III from Viscum album L. ssp. album , 2004, Journal of peptide science : an official publication of the European Peptide Society.

[39]  A. Serrano,et al.  Transfer of bipiperidyl and quinolizidine alkaloids toViscum cruciatum Sieber (Loranthaceae) hemiparasitic onRetama sphaerocarpa boissier (Leguminosae) , 1993, Journal of Chemical Ecology.

[40]  B. Schneider,et al.  [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological coh , 2004, Arzneimittel-Forschung.

[41]  K. Schmidt,et al.  Mistletoe for cancer? , 2003, International journal of cancer.

[42]  N. Arda,et al.  Antiviral potency of mistletoe (Viscum album ssp. album) extracts against human parainfluenza virus type 2 in Vero cells , 2003, Phytotherapy research : PTR.

[43]  F. Berrino,et al.  Mistletoe in cancer - a systematic review on controlled clinical trials. , 2003, European journal of medical research.

[44]  C. Esimone,et al.  Hypoglycemic Properties of Viscum album (Mistletoe) in Alloxan-induced Diabetic Animals , 2003 .

[45]  Ö. Ertürk Antimicrobial Activity of Viscum album L. subsp. abietis (Wiesb) , 2003 .

[46]  Markus Bauer,et al.  Cuticular Waxes and Flavonol Aglycones of Mistletoes , 2003, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[47]  İ. Çalış,et al.  Two New Flavonoid Glycosides from Viscum album ssp. album , 2002 .

[48]  E. Ernst Cancer therapy with mistletoe:hope or hype? , 2002, Journal of herbal pharmacotherapy.

[49]  A. Piotrowski,et al.  Comparative analysis of phenolic acids in mistletoe plants from various hosts. , 2001, Acta poloniae pharmaceutica.

[50]  L. Skidmore-Roth Mosby's Handbook of Herbs & Natural Supplements , 2001 .

[51]  B. Şener,et al.  Evaluation of Antimycobacterial Activity of Viscum album Subspecies , 2001 .

[52]  E. Ernst Mistletoe for cancer? , 2001, European journal of cancer.

[53]  U. Pfüller Chemical Constituents of European Mistletoe (Viscum album L.) Isolation and Characterisation of the Main Relevant Ingredients: Lectins, Viscotoxins, Oligo-/polysaccharides, Flavonoides, Alkaloids , 2000 .

[54]  A. Büssing INTRODUCTION: HISTORY OF MISTLETOE USES , 2000 .

[55]  C. K. Buharalioglu,et al.  Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp. album. , 2000, Journal of ethnopharmacology.

[56]  C. Hyun,et al.  Cytotoxic effects of the components in heat-treated mistletoe (Viscum album). , 1999, Cancer letters.

[57]  P. Flatt,et al.  Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). , 1999, The Journal of endocrinology.

[58]  İ. Çalış,et al.  THE COMPARATIVE STUDIES ON PHENYLPROPANOID GLYCOSIDES OF VISCUM ALBUM SUBSPECIES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY , 1999 .

[59]  M. Giannattasio,et al.  Viscotoxin composition of the three European subspecies of Viscum album. , 1998, Planta medica.

[60]  A. Multani,et al.  Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations. , 1998, Cancer letters.

[61]  B. Geils,et al.  Hosts of Viscum album , 1998 .

[62]  C. Mayr,et al.  Pharmacological activity of phenylpropanoids of the mistletoe, Viscum album L., host: Pyrus caucasica Fed. , 1998, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[63]  A. B. ssing Mistletoe therapy and immunological research , 1997 .

[64]  P. Poindron,et al.  Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. , 1996, Cancer letters.

[65]  P. Verhaert,et al.  Isolation and partial characterization of a small chitin‐binding lectin from mistletoe (Viscum album) , 1996, FEBS letters.

[66]  M. Giannattasio,et al.  Cytotoxicity of Different Viscotoxins and Extracts from the European Subspecies of Viscum album L. , 1996 .

[67]  Prof. Robert Hegnauer Chemotaxonomie der Pflanzen , 1996, Lehrbücher und Monographien aus dem Gebiete der Exakten Wissenschaften.

[68]  N. Bisset Herbal drugs and phytopharmaceuticals , 1994 .

[69]  N. Žarković,et al.  Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel. , 1993, Oncology.

[70]  H. Itokawa,et al.  Studies on the Constituents of the European Mistletoe, Viscum album L. II , 1987 .

[71]  H. Wagner,et al.  Structure and properties of polysaccharides from Viscum album (L.). , 1986, Oncology.

[72]  H. Wagner,et al.  Phenylpropanes and lignans of Viscum album cardioactive drugs V. , 1986, Planta medica.

[73]  H. Franz Inhaltsstoffe der Mistel (Viscum album L.) als potentielle Arzneimittel , 1985 .